Share of Cost, Expand prescribing of buprenorphine for opioid abuse? Experts weigh pros and cons

Tuesday, May. 17th 2016 5:00 AM

Buprenorphine is a critical part of treatment for the growing epidemic of opioid abuse–but also carries the potential for misuse and diversion. The debate over whether ‘to expand or not to expand’ prescribing of buprenorphine for opioid abuse is discussed in an expert review in the Journal of Psychiatric Practice, published by Wolters Kluwer

Posted on Tuesday, May. 17th 2016 5:00 AM | by Share of Cost | in Share of Cost | No Comments »

Leave a Reply

You must be logged in to post a comment.